Compare Hims and Hers Health Inc (HIMS) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs QUALCOMM, Inc. — how do they compare? Hims and Hers Health Inc trades at $32.86 (market cap $7.57B), while QUALCOMM, Inc. trades at $173.7 (market cap $179.52B). The key difference: QUALCOMM, Inc. is far larger — about 23.7× Hims and Hers Health Inc's market cap, and QUALCOMM, Inc. pays a 2.16% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | QCOM | |
|---|---|---|
Market Cap | $7.57B | $179.52B |
Sector | Health | Technology |
52-Week High | $66.18 | $251.10 |
52-Week Low | $14.52 | $124.07 |
Enterprise Value | $7.95B | $184.99B |
Dividend Yield | — | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Qualcomm (QCOM) trades at $171.78, up 0.64% with a bearish technical signal despite recent earnings beats. The company shows strong profitability with 54.8% gross margins and 22.31% net income margins, though revenue growth remains modest. Recent news highlights Qualcomm's AI and data center expansion efforts while facing smartphone market headwinds and increased competition from Nvidia's PC chip entry.
The stock presents a mixed outlook with attractive valuation (P/E 18.31) and analyst consensus target of $228.22 offering 33% upside potential. However, margin pressures and competitive threats from Nvidia's market expansion create near-term uncertainty. Institutional sentiment leans neutral with 50% hold ratings, suggesting cautious optimism about Qualcomm's diversification strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
